ValueVitals - Lessons from Pharma - Build a Payer Value Proposition

In this article, we continue our exploration of how pharma builds and proves value for the payer audience. In PART 1, we saw how to "make it matter" to payers. We learned that

Payer Value Proposition

Series

Value-Based Healthcare

Proving Value to Payers, Lessons from Pharma, PART 2 of 3: Class Differentiation

We are continuing to explore a textbook case of how pharma proves value to the payer audience. This is PART 2 in a series of 3 articles exploring a textbook case

by ValueVitals

Series

Value-Based Healthcare

Proving Value to Payers, Lessons from Pharma, PART 1 of 3: Make it Matter

Do you know how the pharmaceutical industry (i.e., "pharma") proves value to payers? They've been doing it for decades to help sell billions of dollars of medication. Once they convince payers their

by ValueVitals

Payer Value Proposition

Value-Based Healthcare

Grow Your Reimbursements with a Payer Value Proposition

Dealing with payers can be painful for providers! You deliver healthcare services, and then have to fight tooth-and-nail for every dime you are owed. Unfortunately, payers have created a complicated reimbursement system,

by ValueVitals

Outcomes Research

What is Outcomes Research, and Why Should it Matter to the Practice Owner?

Have you heard the term “outcomes research”? Sure, it might be an interesting scientific discipline in medicine… but why does that matter to your medical practice? Simple… Because it matters (in a big

by ValueVitals

Health Economics

Outcomes Research

What is Health Economics, and Why Should it Matter to the Practice Owner?

Have you heard the term “health economics”? Sure, you kind of understand what it might include, but did you realize that it is actually an entire scientific discipline? Moreso, did you realize

by ValueVitals

Value Vitals - Market Access - Chain-link fence

Health Economics

Outcomes Research

What is Market Access, and Why Should it Matter to the Practice Owner?

Do you ever consider your medical practice as part of the healthcare “market?” If not, you should start. Why? Because payers look at you that way… And payers represent a lot of your

by ValueVitals

Value Vitals - Drug Pricing Policy Should Penicillin Cost 2 Million Dollars

Value-Based Healthcare

Drug Pricing Policy: Should Penicillin Cost $2,000,000?

Recently, I attended an oncology medical conference that reminded me about the importance of understanding the role of drug pricing policy. Needless to say, there was a lot of discussion about the high cost of

by ValueVitals

Value Vitals - One Easy Way to Prove Value in Healthcare

Payer Value Proposition

Value-Based Healthcare

A Simple 2-Step Formula to Prove Value in Healthcare

It doesn't have to be complicated to prove value in healthcare. Below, you will learn a simple 2-step formula you can start using today to dramatically boost your bottom line. I recently

by ValueVitals

Value-Based Healthcare

3 Drug Industry Challenges in Targeting Patient Value

Drug companies are getting better at targeting patient value. In 2010, a drug company was working on new ways to differentiate their cancer drug (Drug 2) from the market leader (Drug 1). Both drugs had

by ValueVitals

« Older Articles Newer Articles »